Lasix (Furosemide)

Furosemide works by inhibiting the Na⁺‑K⁺‑2Cl⁻ cotransporter in the thick ascending limb of the loop of Henle. This blockade prevents reabsorption of sodium, chloride, and potassium, leading to increased urinary loss of these ions together with water, which reduces extracellular fluid volume and lowers blood pressure.

The appropriate dose of Lasix is determined by the prescribing clinician based on the individual patient's condition, severity of fluid overload, renal function, and response to therapy. Dosing may be adjusted for intramuscular or intravenous administration and should follow local prescribing guidelines.

The pregnancy category for furosemide is not definitively established, and limited data are available. Use during pregnancy or lactation should only occur when the potential benefit justifies the potential risk to the fetus or infant, and it should be prescribed under close medical supervision.

To order Lasix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then provide pricing, availability, shipping details (including cold‑chain if needed), and assist with any required import documentation.

Lasix belongs to the loop diuretic class, which is more potent than thiazide or potassium‑sparing diuretics for inducing rapid diuresis. It acts on the loop of Henle, leading to greater sodium and water loss, making it the preferred choice for severe edema and acute hypertension, whereas thiazides are typically used for milder fluid retention.

Lasix injection should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze the solution, and ensure that any reconstituted solution is used within the time frame specified by the manufacturer.

Lasix is supplied as an injectable solution for intramuscular or intravenous use. The route, rate, and volume of administration are determined by the prescriber, who may give a slow IV push, an infusion, or an IM injection depending on the clinical situation and the desired speed of diuresis.

The most serious adverse events include acute renal failure, severe electrolyte disturbances such as profound hypokalemia or hyponatremia, and ototoxicity leading to hearing loss, particularly with high‑dose intravenous administration. Patients should be monitored closely for changes in kidney function, electrolyte levels, and auditory symptoms.

Lasix is contraindicated in patients with anuria (no urine output), known hypersensitivity to furosemide or other sulfonamide drugs, and in individuals with severe electrolyte depletion without appropriate replacement. Caution is also advised for patients with severe hepatic impairment, uncontrolled hypotension, or those taking other ototoxic medications.